The global gene synthesis market is estimated to be valued at USD 1,089.3 million in 2025 and is projected to reach USD 6,203.6 million by 2035, registering a compound annual growth rate of 19% over ...

Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Ginkgo Bioworks, which is building the leading platform for ...

SOUTH SAN FRANCISCO, Calif. & BOSTON, May 08, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care ...

Company to discuss news during earnings call and webcast today at 8:00am ET Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...

Twist Bioscience Spins Out DNA Data Storage as Independent Company Provided by Business Wire May 5, 2025, 11:10:00 AM ...

Company Overview Twist Bioscience specializes in synthetic DNA and DNA-based products for various applications in life sciences. With a market capitalization of approximately $3.1 billion as of ...

Twist Bioscience Corporation (NASDAQ: TWST), a player in the U.S. Life Science Tools & Diagnostics sector, has been making strides in operational efficiency and product development.

PORTLAND, OR, UNITED STATES, November 6, 2024 /EINPresswire / -- The global gene synthesis market is on a transformative growth trajectory, rising from $1,110 million in 2021 to a projected $5,979 ...

SOUTH SAN FRANCISCO, Calif., August 08, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...